PAXVAX
PaxVax is a vaccine start-up company developing candidate oral vaccines for influenza, and key infectious diseases. It has developed a proprietary oral vaccine technology based on a common virus called adenovirus. The technology removes the delivery hurdles of traditional injectable vaccines, namely the need for cold storage, needles, and administration by medical personnel. PaxVax was founded in 2007 and is headquartered in Gaithersburg, Maryland.
PAXVAX
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2007-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.paxvax.com
Total Employee:
251+
Status:
Active
Contact:
8584500544
Total Funding:
234.61 M USD
Technology used in webpage:
SPF IPv6 Microsoft Azure DNS Contact Form 7 Cloudflare Hosting Cloudflare DNS Amazon S3 Cisco Ironport Cloud Advanced Custom Fields Pro GFI
Similar Organizations
+3S
+3S specializes in the research, development, production and operation of antitoxin and antiserum biological products.
AB Pharma
AB Pharma is a pharmaceutical company that engages in the development and production of innovative drugs.
Actuate Therapeutics
Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Affigen
A St. Louis startup developing drugs that target specific molecules in cancerous tumors.
Agilvax
Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases.
Alchemab Therapeutics
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Alpha Genesis, Inc.
Alpha Genesis is a full=service primate research center that provides nonhuman primate products and bio-research services world-wide
Alzprotect
It is a biopharmaceutical company which develop new bioactive molecules for the treatment of neurodegenerative diseases.
Amplyx Pharmaceuticals
Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
AQUA Therapeutics
AQUA Therapeutics primarily engages in the development of therapeutic drugs for the treatment of fibrotic diseases.
ASSURED PHARMACY
Assured Pharmacy is a chain of specialty pharmacies providing advanced prescription services for medical professionals and their patients.
AVM Biotechnology
AVM Biotechnology is a clinical stage company.
CaaMTech
CaaMTech is developing and optimizing psychedelic compounds to build a patent portfolio.
Calypso Biotech
Calypso Biotech's vision is to give new hope to patients suffering from severe gastro-intestinal diseases.
CASI Pharmaceuticals
CASI focus on building a pipeline through mutually beneficial business development transactions.
Cerespir
Cerespir is an operator of a biotechnology company intended to treat neurodegenerative disorders.
CONTINUUS Pharmaceuticals
Continuus Pharmaceuticals designs, builds, and runs manufacturing processes for pharmaceutical and generic clients.
Cotinga Pharmaceuticals
Cotinga Pharmaceuticals discovers and develops drug therapies for diseases.
Decipher Biosciences
Decipher Biosciences offers genomic tests for urological cancers.
Diatech Pharmacogenetics
Diatech Pharmacogenetics is an Italian Precision Medicine company.
DTRM Biopharma
Biopharma company conducting clinical trials for cancer research.
Evgen Pharma
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions
Fimecs
FIMECS is a focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases.
FirstString Research
FirstString Research is a biopharma company improving marginal allograft outcomes through cell junction stabilization in transplantation.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
HLS Therapeutics
HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity.
IMV Inc
IMV Inc applies its novel platform to the development of vaccines for cancer therapy, infectious diseases, and animal health.
Inspiration Healthcare Group
IHG is a clinical development organization providing clinical trial services for biotechnology and pharmaceutical companies.
Izun Pharmaceuticals
Izun Pharmaceuticals develops non-steroidal topical oral anti-inflammatory therapies for periodontal treatments.
Knight Therapeutics
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing
Kolltan Pharmaceuticals
Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.
Madam Therapeutics
Madam Therapeutics is a biotech startup, developing sustainable, pragmatic solutions to alleviate the burden of infectious diseases.
Moleculin
Moleculin is a pharmaceutical company developing dermatological products to treat skin disorders.
Murli Krishna Pharma
Murli Krishna Pharma is a young and dynamic drug delivery systems (DDS) company in India that provides a range of effective solutions.
Oncovet Clinical Research
Oncovet Clinical Research develops medicine for human and animal illnesses.
PlantExt
PlantExt develops medical cannabis products intended to provide anti-inflammatory remedies.
Presidio Pharmaceuticals
Presidio Pharmaceuticals discovers, develops and commercializes novel therapeutics for viral infections, including HCV and HIV.
Protégé Biomedical
Protégé Biomedical is a company with a unique new line of hemostatic products developed to stop bleeding in animals and humans*.
ReFlow Medical
ReFlow Medical is a company developing technologies for diseases related to arrangement of blood vessels.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Stem Cell Reserve
Revolutionizing Regenerative Medicine.
Torus Biosystems
Torus Biosystems is a biotech startup that delivers molecular diagnostics for infectious diseases.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Vaccine and Infectious Disease Organization
Vaccine and Infectious Disease Organization is a world leader in developing vaccines and technologies against infectious diseases.
Vaxxinity
Vaxxinity is a biotechnology company that enables the innovation of synthetic peptide vaccines to prevent or treat infectious diseases.
Vedanta Biosciences
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
Xbiome
Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Kenneth Kelley Co-Founder, CEO & Director @ PaxVax
Co-Founder, CEO & Director
2007-01-01
Thomas P. Monath CTO @ PaxVax
CTO
Paul Shabram VP Operations @ PaxVax
VP Operations
2007-07-01
Founder
Investors List
Ignition Capital
Ignition Capital investment in Private Equity Round - PaxVax
Cerberus Capital Management
Cerberus Capital Management investment in Private Equity Round - PaxVax
Blue Haven Initiative
Blue Haven Initiative investment in Series B - PaxVax
Pharmakon Advisors
Pharmakon Advisors investment in Debt Financing - PaxVax
Ignition Partners
Ignition Partners investment in Series B - PaxVax
Ignition Capital
Ignition Capital investment in Series B - PaxVax
Ignition Partners
Ignition Partners investment in Series B - PaxVax
Blue Haven Initiative
Blue Haven Initiative investment in Series B - PaxVax
Ignition Partners
Ignition Partners investment in Venture Round - PaxVax
Official Site Inspections
http://www.paxvax.com
- Host name: 104.21.34.198
- IP address: 104.21.34.198
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PaxVax"
PaxVax - Crunchbase Company Profile & Funding
Organization. PaxVax . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. PaxVax is a start-up developing candidate oral …See details»
PaxVax | Fierce Pharma
PaxVax is a leading independent vaccine company that is devoted to bringing specialty vaccines that protect against overlooked infectious diseases to market, providing effective tools for …See details»
PaxVax Inc. Company Profile | Gaithersburg, MD | Competitors ...
Find company research, competitor information, contact details & financial data for PaxVax Inc. of Gaithersburg, MD. Get the latest business insights from Dun & Bradstreet.See details»
PaxVax 2025 Company Profile: Valuation, Investors, Acquisition
PaxVax General Information Description. Developer of oral vaccines against infectious diseases. The company develops a proprietary adenoviral-based technology platform enabling the …See details»
PaxVax, Inc. Information - RocketReach
Emergent BioSolutions has acquired PaxVax Inc. Emergent BioSolutions is a global specialty biopharmaceutical company seeking to protect and enhance life by offering specialized …See details»
Emergent BioSolutions to Acquire Specialty Vaccines Company …
PaxVax is majority owned by an affiliate of Cerberus Capital Management, L.P. Upon the closing of the transaction, Emergent will acquire: Vivotif ® (Typhoid Vaccine Live Oral Ty21a), the only …See details»
PaxVax - Overview, News & Similar companies | ZoomInfo.com
Who is PaxVax. About PaxVax PaxVax is a leading independent vaccine company that is devoted to bringing specialty vaccines that protect against overlooked infecti ous diseases to market, …See details»
PaxVax - Contacts, Employees, Board Members, Advisors & Alumni …
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
EMERGENT BIOSOLUTIONS COMPLETES ACQUISITION OF …
COMPANY PAXVAX GAITHERSBURG, Md., October 4, 2018—Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of PaxVax, a company …See details»
PaxVax - Funding, Financials, Valuation & Investors - Crunchbase
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases. New. Resources. Advanced Search ... Experience the new Crunchbase, powered by AI . Experience …See details»
www.paxvax.com
Www.paxvax.comSee details»
PaxVax - Tech Company Profile - Gaebler.com Venture Capital …
PaxVax. PaxVax is a leading biopharmaceutical venture, located in Redwood City. Venture investment and financing was provided by Cerberus Capital Management, Blue Haven …See details»
Companies To Watch: PaxVax - Life Science Leader
Jan 2, 2015 Founded in 2007, expressly “in response to the global threat of the H5N1 pandemic,” PaxVax is developing its new vaccine technology “in a socially responsible manner …See details»
Emergent BioSolutions to Acquire PaxVax from Cerberus Capital …
Aug 9, 2018 PaxVax is a leading independent vaccine company that is devoted to bringing specialty vaccines that protect against overlooked infectious diseases to market, providing …See details»
PaxVax | Fierce Healthcare
PaxVax is a leading independent vaccine company that is devoted to bringing specialty vaccines that protect against overlooked infectious diseases to market, providing effective tools for …See details»
Working at PaxVax, inc: 4 Reviews - Indeed
Reviews from PaxVax, inc employees about PaxVax, inc culture, salaries, benefits, work-life balance, management, job security, and more.See details»
PaxVax Announces New Commercial Senior Leadership …
Mar 7, 2014 PaxVax is a privately held specialty vaccine company founded in 2007. PaxVax is focused on traveler vaccines with an emerging pipeline in biodefense coupled with a social …See details»
The unprecedented Paxlovid journey from milligrams to millions of ...
Mar 20, 2025 The spread of SARS-CoV-2 infection led to a global pandemic, resulting in >770 million cases and 7.1 million deaths to date 1.Fast-paced vaccine development led to the …See details»
PaxVax - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 25, 2025 PaxVax has raised a total funding of $212M over 9 rounds. Its first funding round was on Nov 06, 2009. Its latest funding round was a Series C round on Dec 08, 2015 for …See details»
PaxVax | VentureRadar
Founded in 2007, PaxVax is a fully integrated specialty vaccine company with a mission to protect people from infectious diseases. The company seeks both financial returns through two …See details»